Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002517604 | SCV003259578 | uncertain significance | not provided | 2023-10-09 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 429 of the TET2 protein (p.Gly429Arg). This variant is present in population databases (rs201642693, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with TET2-related conditions. ClinVar contains an entry for this variant (Variation ID: 135318). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV003147341 | SCV003835255 | uncertain significance | Immunodeficiency 75 | 2022-08-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002517604 | SCV003936371 | uncertain significance | not provided | 2023-06-28 | criteria provided, single submitter | clinical testing | Identified in a bone marrow specimen from an individual with AML in published literature (Li et al., 2016) and in either a bone marrow specimen or in peripheral blood of an unrelated individual with AML (Gaidzik et al., 2012); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 22430270, 24728327, 36580013, 26414667) |
ITMI | RCV000122133 | SCV000086348 | not provided | not specified | 2013-09-19 | no assertion provided | reference population |